Of note, in the multivariate model, adjusting for BMI, age, ethnicity, insulin therapy during pregnancy, family history of T2D, and metabolic syndrome, BF reduced by 58% the likelihood of glycemic alterations at OGTT [33]. This evidence concerns the gene INS and type 2 diabetes mellitus.